Clinical Trial Update: Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of trastuzumab, docetaxel, and carboplatin in women with stage II/III or inflammatory breast cancer; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Paraplatin (Carboplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-11-20